The United States Food and Drug Administration has granted final approval to Zydus Lifesciences for Levothyroxine Sodium for Injection, 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial (USFDA). The injection of levothyroxine sodium is used to treat myxedema coma. The drug will be produced at the group’s injectable manufacturing facility in Jarod, which is located near Vadodara (India).
Shopping Cart